Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
32.06
+1.14 (3.69%)
Aug 4, 2025, 4:00 PM - Market closed
ShockWave Medical Employees
Artivion had 1,600 employees as of December 31, 2024. The number of employees increased by 100 or 6.67% compared to the previous year.
Employees
1,600
Change (1Y)
100
Growth (1Y)
6.67%
Revenue / Employee
$243,803
Profits / Employee
-$13,344
Market Cap
1.51B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,600 | 100 | 6.67% |
Dec 31, 2023 | 1,500 | 200 | 15.38% |
Dec 31, 2022 | 1,300 | 0 | - |
Dec 31, 2021 | 1,300 | 100 | 8.33% |
Dec 31, 2020 | 1,200 | 0 | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AORT News
- 5 days ago - Artivion to Participate in Upcoming Investor Conferences - PRNewsWire
- 11 days ago - Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock - PRNewsWire
- 2 months ago - Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock - PRNewsWire
- 3 months ago - Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Artivion Reports First Quarter 2025 Financial Results - PRNewsWire
- 3 months ago - Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting - PRNewsWire
- 3 months ago - Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results - PRNewsWire